Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.
New real-world and implementation study data highlight the efficacy of ViiV’s long-acting injectables for HIV prevention and ...
The health clinic where Alice Okwirry collects her HIV medication in Kenya's capital Nairobi has been rationing supplies of ...
Gilead released data showing that an HIV drug, called lenacapavir, could provide virtually complete protection against ...
18h
LGBTQ Nation on MSNOnce-a-year shot for HIV protection passes early safety trialAn annual shot to protect against HIV infection has successfully passed an early safety trial, according to research ...
| Dr. Buzón discusses bridging science and reality, highlighting the vital role of real-world evidence in advancing HIV care ...
UCSF researchers are the first to confirm that this approach is effective for the patients who need it most. Patients who ...
2d
MedPage Today on MSNHundreds of Scientists, Doctors, Activists Rally for HIV Research FundingSAN FRANCISCO -- At least 400 researchers, physicians, activists, and other concerned citizens gathered here Monday night to ...
Modern HIV treatment offers remarkable outcomes. This guide explores essential first steps, treatment advances, support ...
4h
AllAfrica on MSNJournalists Trained in Ethical Reporting to Boost HIV/Aids AwarenessAccurate and ethical journalism on HIV/AIDS plays a vital role in shaping public perceptions, encouraging behavioral change, and raising awareness. Misinformation or vague reporting, however, can ...
Offering mailed self-testing for HIV encouraged patients to test themselves for HIV but require methods of improving ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results